Personalized prognosis: construction and validation of a survival prediction model for older postoperative differentiated thyroid cancer patients.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: postoperative differentiated thyroid cancer (DTC) is influenced by multiple factors
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] This nomogram provides a robust tool for assessing OS in older postoperative DTC patients. Further studies should refine models with updated prognostic factors.
[BACKGROUND] The prognosis of older patients with postoperative differentiated thyroid cancer (DTC) is influenced by multiple factors.
APA
Mu Y, Zhang S, et al. (2026). Personalized prognosis: construction and validation of a survival prediction model for older postoperative differentiated thyroid cancer patients.. BMC geriatrics, 26(1). https://doi.org/10.1186/s12877-026-07178-3
MLA
Mu Y, et al.. "Personalized prognosis: construction and validation of a survival prediction model for older postoperative differentiated thyroid cancer patients.." BMC geriatrics, vol. 26, no. 1, 2026.
PMID
41772439
Abstract
[BACKGROUND] The prognosis of older patients with postoperative differentiated thyroid cancer (DTC) is influenced by multiple factors. This study aimed to develop a nomogram to predict overall survival (OS) in older DTC patients.
[METHODS] Data for 11,283 DTC patients aged 60 or older, diagnosed between 2000 and 2020, were extracted from the SEER database. Patients were randomly split into training and validation cohorts. Clinical variables associated with OS were selected using Least Absolute Shrinkage and Selection Operator (LASSO) regression with cross-validation. Model performance was assessed with the concordance index (C-index), calibration curves, and time-dependent area under the receiver operating characteristic curve (AUC). The nomogram’s clinical value was compared to the TNM staging system using decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). K-fold cross-validation was applied to validate model robustness, and Kaplan–Meier analysis compared survival across risk groups.
[RESULTS] Ten variables were used to construct the nomogram. The nomogram achieved a C-index of 0.763 in the training and 0.739 in the validation cohorts, with AUCs over 0.75. Calibration showed good prediction alignment. NRI and IDI values demonstrated the nomogram’s superiority over TNM staging ( < 0.05). DCA suggested strong clinical applicability.
[CONCLUSIONS] This nomogram provides a robust tool for assessing OS in older postoperative DTC patients. Further studies should refine models with updated prognostic factors.
[METHODS] Data for 11,283 DTC patients aged 60 or older, diagnosed between 2000 and 2020, were extracted from the SEER database. Patients were randomly split into training and validation cohorts. Clinical variables associated with OS were selected using Least Absolute Shrinkage and Selection Operator (LASSO) regression with cross-validation. Model performance was assessed with the concordance index (C-index), calibration curves, and time-dependent area under the receiver operating characteristic curve (AUC). The nomogram’s clinical value was compared to the TNM staging system using decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). K-fold cross-validation was applied to validate model robustness, and Kaplan–Meier analysis compared survival across risk groups.
[RESULTS] Ten variables were used to construct the nomogram. The nomogram achieved a C-index of 0.763 in the training and 0.739 in the validation cohorts, with AUCs over 0.75. Calibration showed good prediction alignment. NRI and IDI values demonstrated the nomogram’s superiority over TNM staging ( < 0.05). DCA suggested strong clinical applicability.
[CONCLUSIONS] This nomogram provides a robust tool for assessing OS in older postoperative DTC patients. Further studies should refine models with updated prognostic factors.
같은 제1저자의 인용 많은 논문 (5)
- Proliferative double-negative T (DNT)-cell responses to PD-1 blockade therapy were positively correlated with good clinical outcomes in non-small cell lung cancer patients.
- Deciphering the Effect of Methyl 4‑Hydroxybenzoate on Breast Cancer by Bioinformatics and Experiments.
- Retraction of: Glypican-1-targeted and gemcitabine-loaded liposomes enhance tumor-suppressing effect on pancreatic cancer.
- Recurrent hyperammonemic encephalopathy in a breast cancer patient receiving capecitabine therapy: a case report and literature review.
- Recurrent laryngeal never monitoring versus non-monitoring in parathyroid surgery.